TMS with cognitive training for mild Alzheimer's dementia
Part of Brain & nervous system, Mental health clinical trials.
This study tests a combination of brain stimulation (TMS) and cognitive training to improve memory and thinking in people with mild Alzheimer's. It may help if you are already on a stable dose of a donepezil-type medication and have a confirmed Alzheimer's diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 60 and 85 years old.
- You have mild Alzheimer's disease confirmed by a special brain scan (amyloid PET-CT).
- You have been taking a medication like donepezil for at least 2 months at the same dose.
- You score between 21 and 26 on the MMSE memory test, and your dementia stage is rated as mild (CDR 1 or GDS 3).
- You can attend all visits for 24 weeks with a caregiver who can help consent.
- You speak Korean as your first language and have no other brain conditions that explain your memory loss.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether combining brain stimulation (TMS) with cognitive training games can help people with mild cognitive impairment—early memory and thinking problems. The goal is to see if this combination improves thinking abilities and slows cognitive decline.
This study tests whether a painless brain stimulation technique (called tACS) combined with computer-based memory exercises can improve thinking and memory in people with mild Alzheimer's disease. Participation involves using the stimulation device at home with the help of a trained caregiver.
This study tests whether a new type of brain stimulation (called repetitive transcranial magnetic stimulation, or rTMS) with a larger coil can improve memory and thinking in people with mild to moderate Alzheimer's disease. It involves multiple sessions of rTMS and MRI scans.
This trial tests a personalized brain stimulation treatment for older adults with mild memory or thinking problems caused by Alzheimer's disease. It aims to see if tailored stimulation can improve cognitive function.
This trial tests whether transcranial magnetic stimulation (TMS), a noninvasive brain treatment, can help people with early Alzheimer's or mild cognitive impairment. It aims to see if the treatment is safe and effective for slowing memory decline.
This study tests a non-invasive brain stimulation technique called transcranial alternating current stimulation (tACS) to see if it can improve memory and thinking in people with early Alzheimer's disease. It may offer a new way to help manage symptoms.
Hear when a new Alzheimer’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.